Quality by Design Formulation Approach for the Development of Orodispersible Tablets of Dexlansoprazole
Drug Design, Development and Therapy · 2025-05 · Volume 19 · 4163-4181
DOI: 10.2147/dddt.s515139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025-05. Verfasst von Arbab Tahir Ali und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Peshawar, Peshawar, Pakistan. Hauptthemen laut MEDLINE: Dexlansoprazole, Proton Pump Inhibitors, Drug Design. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Peshawar, Peshawar, Pakistan.
- Department of Pharmacy CECOS University Peshawar, Peshawar, Pakistan.
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.
- Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA, 19104, USA.
- Department of Pharmacy, Qurtaba University of Science and Information Technology, Peshawar, 25000, Pakistan.
ORCID-Profile: Arbab Tahir Ali
Zitieren
APA
Ali, A. T., Nasir, F., Hidayatullah, T., Pervez, S., Rabqa Zainab, S., Gohar, S., Ur Rahman, A., Khattak, M. A., Alasmari, F., Neau, S. H., & Maryam, G. E. (2025). Quality by Design Formulation Approach for the Development of Orodispersible Tablets of Dexlansoprazole. Drug Design, Development and Therapy, Volume 19, 4163-4181. https://doi.org/10.2147/dddt.s515139
Vancouver
Ali AT, Nasir F, Hidayatullah T, Pervez S, Rabqa Zainab S, Gohar S, et al. Quality by Design Formulation Approach for the Development of Orodispersible Tablets of Dexlansoprazole. Drug Design, Development and Therapy. 2025;Volume 19:4163-4181. doi:10.2147/dddt.s515139
BibTeX
@article{Ali2025,
author = {Ali, Arbab Tahir and Nasir, Fazli and Hidayatullah, Talaya and Pervez, Sadia and Rabqa Zainab, Syeda and Gohar, Shazma and Ur Rahman, Altaf and Khattak, Muzna Ali and Alasmari, Fawaz and Neau, Steven H and Maryam, Gul E},
title = {Quality by Design Formulation Approach for the Development of Orodispersible Tablets of Dexlansoprazole},
journal = {Drug Design, Development and Therapy},
year = {2025},
volume = {Volume 19},
pages = {4163--4181},
doi = {10.2147/dddt.s515139}
}
EUVIMED